Mixed phenotype acute leukemia (MPAL) is recognized as a rare form of leukemia, with an incidence rate of <2–3%. The prevalent subtypes include B-cell and myeloid and T-cell and myeloid, while B-cell and T-cell and trilineage MPAL are exceedingly uncommon. We report a case involving a 23-year-old male who presented with acute leukemia but exhibited no peripheral cytopenias. Flow cytometry and immunohistochemistry revealed a singular population of blasts that expressed markers for both B-cell and T-cell lineages. Initially, the patient was treated using the augmented Berlin-Frankfurt-Münster protocol; however, there was no peripheral clearance of blasts observed on Day 7, and the bone marrow did not achieve remission by Day 35 following therapy.
No takes yet. Share an insight, caveat, or question.
Dayal Singh Bisht (2026) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: